[Key Question 5] Clinical pipeline progress
Dear Shareholders,
Recently, some shareholders have expressed negative opinions about the company through online media and have been informed that they are sharing related information with about 100 shareholders who use online media together.
Since the second half of last year, the shareholder has continuously inquired through our IR email. So, we have consistently responded to you sincerely within the legal framework.
However, there were many difficulties internally as the amount of e-mail that exceeded common sense and emotional words and deeds continued.
At the general meeting of shareholders, the executives directly answered the questions asked by the relevant shareholder and faithfully answered the plans for the future.
However, these shareholders continue to have a negative impact on us.
However, we will not be shaken.
This is because, despite the management crisis due to the change of the CEO and the death of the CEO, the external auditor's opinion was appropriate,
and the business report was also disclosed promptly.
This proves that we have overcome with sincerity and courage even in situations that can cause great crises.
What we are really worried about is that if the unilateral actions of minority shareholders negatively affect the normal business of the company,
it will be a loss not only for the company but also for the majority of shareholders who are patiently waiting for any situation.
In this regard, we will respond boldly, and we will document all damages caused by the actions of minority shareholders and secure all relevant evidence so that legal action can be taken if damages to all shareholders occur in the future.
We promise that we will work diligently and unwaveringly for our shareholders who trust and support us.
In the meantime, SCM Life Sciences Co., Ltd., unlike other companies, responded to the shareholder phone call faithfully directly by an executive acting on behalf of the current CEO,
not by an IR employee. In addition, he checked all IR emails, and he faithfully answered questions by discussing them with the executives.
Dear Shareholders,
Unlike other companies, despite our busy schedules, the top management of our company communicated directly with all of you.
The reason for this is that the deceased CEO Sun-Uk Song and the executive who received the phone call from shareholders committed to showing the sincerity of SCM Lifescience, Inc. to shareholders.
We did our best in the attitude of serving our shareholders without revealing it.
Therefore, please refrain from making insults to our sincerity.
In the two weeks after the shareholders' meeting, 50 executives and employees focused on appointing CEOs, communicated clearly with the largest shareholders about corporate management,
and updated IR plans and IR data in cooperation with specialized IR companies for new communication with institutional investors.
In addition, we plan to inform you of our specific measures for shareholder communication.
SCM Lifescience, Inc. will adhere to the following communication principles to legally protect the rights and interests of shareholders.
▶ The company's information will be notified to everyone through the website at the same time.
▶ We do not provide new company information through IR-only emails and shareholder phone calls.
▶ We will not respond to emotional e-mails and degrading words and actions.
▶ We will continue to inform you of the investment judgment criteria for SCM Lifescience, Inc.
▶ For data not directly generated by SCM Life Sciences, such as Co-Immune information,
we will inform you directly within the agreed range after we agree on the information provider and the scope of information disclosure.
SCM Lifescience, Inc. will faithfully respond to the public relations center notice regarding continuous inquiries.
SCM Lifescience, Inc. will hold an extraordinary general meeting of shareholders and the board of directors for the appointment of the CEO as soon as possible.
I would like to have a sincere place with the shareholders at the extraordinary general meeting of shareholders, where the CEO who will be with us in the future of our company is decided.
We hope that the shareholders will understand and support the current situation with a greater heart.